# Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)

> **NCT07245264** · PHASE2,PHASE3 · RECRUITING · sponsor: **St. Olavs Hospital** · enrollment: 274 (estimated)

## Conditions studied

- Chronic Subdural Hematoma

## Interventions

- **DRUG:** Tranexamic Acid (Cyklokapron)

## Key facts

- **NCT ID:** NCT07245264
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-10
- **Primary completion:** 2028-11-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 274 (ESTIMATED)
- **Last updated:** 2025-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07245264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07245264, "Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07245264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*